The Techspert.io expert network was founded in 2015, as a machine-driven expert network in Cambridge, UK. It started out with a broader service offering for life sciences under the name Biotechspert, but successfully pivoted into expert calls and raised venture capital during 2018. Techspert is specialized on experts within life sciences (medical devices, pharmaceuticals, biotechnology and diagnostics), a focus that it shares with Bioinformatics Inc, Experts OnTap and Bioexpert Network.
Techspert.io secured €1.1m first round funding in December 2018 and additional £3.75 million Series A funding in February 2020. In February 2021, Techspert.io opened its first US office in Houston, Texas.
As of February 2021, the firm had 42 employees.
Techspert.io is one of the handful of firms outright stating they use AI and machine learning in their work. Other such “machine-driven expert networks” include Xperiti, NewtonX, ENG llc, CleverX, Prosapient and Atheneum (after its acquisition of Chime Advisors).
Investing in tech can be costly. Whereas expert networks are often turnkey profitable, a range of younger firms in the expert network industry (Inex One included) invest in technology and growth, accepting initial losses.
Aside from the standard expert consultations Techspert.io also offers data review and appraisal services, expert surveys, and participation in multi-expert focus groups. Unlike the large traditional expert networks, Techspert.io does not rely on a database of pre-vetted experts. The company states that its AI tools can review profiles of 150 million potential experts from different sources in a matter of minutes, which is 200 times more profiles than GLG’s expert pool, the largest in the industry, contains.
In August 2020, Techspert announced a "Feasibility Calculator" to quickly assess the expected number of experts available for every project. If it works as advertised, this tool helps solve a major challenge in the expert network industry.